Related Experiment Video
Updated: Aug 23, 2025

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Longitudinal Clinical and Biological Characteristics in Juvenile-Onset Huntington's Disease
Jordan L Schultz1,2,3, Douglas R Langbehn1, Hend M Al-Kaylani1
1Department of Psychiatry, Carver College of Medicine at the University of Iowa, Iowa City, Iowa, USA.
Juvenile-onset Huntington's disease (JOHD) shows significant striatal volume loss and motor decline. These findings suggest brain imaging and motor scores as potential biomarkers for JOHD clinical trials.
Area of Science:
- Neurology
- Genetics
- Biomarkers
Background:
- Juvenile-onset Huntington's disease (JOHD) is a rare form of Huntington's disease (HD) with onset before age 21.
- Limited observational data exists for this pediatric HD cohort.
Purpose of the Study:
- To quantify disease progression measures in JOHD patients.
- To identify potential biomarkers for clinical trials in JOHD.
Main Methods:
- The Kids-JOHD study included 26 JOHD participants and 78 gene non-expanded (GNE) controls.
- Data collected between 2006 and 2020 compared striatal volume and Unified Huntington's Disease Rating Scale Total Motor Score.
Main Results:
- JOHD patients experienced a mean annualized striatal volume decrease of -3.99% versus -0.06% in GNE controls.
- JOHD patients showed a mean annual increase of 7.29 points in motor score, unlike GNE controls (-0.21 points).
Conclusions:
- Structural brain imaging and clinical motor scores show potential as biomarkers for JOHD progression.
- Larger collaborative studies are needed to validate these findings in JOHD patients.
Related Concept Videos
Longitudinal Research
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Longitudinal Studies
Sex-linked Disorders
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview

